SANGUINE CORP
SB-2, EX-27, 2000-11-01
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: SANGUINE CORP, SB-2, EX-23, 2000-11-01
Next: HANCOCK JOHN VARIABLE ANNUITY ACCOUNT I, 485BPOS, 2000-11-01


WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE>    5

<S>                             <C>                  <C>
<PERIOD-TYPE>                   12-MOS               6-MOS
<FISCAL-YEAR>              DEC-31-1999           DEC-31-2000
<PERIOD-END>               DEC-31-1999           JUN-30-2000
<CASH>                            1062                  4521
<SECURITIES>                         0                     0
<RECEIVABLES>                        0                     0
<ALLOWANCES>                         0                     0
<INVENTORY>                          0                     0
<CURRENT-ASSETS>                  1062                  4521
<PP&E>                               0                     0
<DEPRECIATION>                       0                     0
<TOTAL-ASSETS>                    1062                  4521
<CURRENT-LIABILITIES>           809866                865553
<BONDS>                              0                     0
                0                     0
                          0                     0
<COMMON>                         23163                 24569
<OTHER-SE>                     (831967)              (885601)
<TOTAL-LIABILITY-AND-EQUITY>      1062                  4521
<SALES>                              0                     0
<TOTAL-REVENUES>                     0                     0
<CGS>                                0                     0
<TOTAL-COSTS>                        0                     0
<OTHER-EXPENSES>                217864                416176
<LOSS-PROVISION>                     0                     0
<INTEREST-EXPENSE>               16746                 25118
<INCOME-PRETAX>                (201118)              (441294)
<INCOME-TAX>                         0                     0
<INCOME-CONTINUING>                  0                     0
<DISCONTINUED>                       0                     0
<EXTRAORDINARY>                      0                     0
<CHANGES>                            0                     0
<NET-INCOME>                   (201118)              (441294)
<EPS-BASIC>                    (0.01)                (0.00)
<EPS-DILUTED>                    (0.01)                (0.00)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission